Eli Lilly Stock Slides Pre-Market On Weight-Loss Drug Sales Miss, …

Oct 30, 2024 · Eli Lilly & Co. shares fell over 9% in pre-market trading Wednesday after the company’s third-quarter profit and revenue missed analyst expectations by a wide margin. …

CouponFollow Extension

9%
OFF

Eli Lilly Stock Slides Pre-Market On Weight-Loss Drug Sales Miss, …

3 weeks from now

Oct 30, 2024 · Eli Lilly & Co. shares fell over 9% in pre-market trading Wednesday after the company’s third-quarter profit and revenue missed analyst expectations by a wide margin. …

stocktwits.com

121%
OFF

Eli Lilly Plummets On Rare — But 'Big' — Sales Miss For ... - MSN

3 weeks from now

Eli Lilly stock crashed Wednesday after the pharma giant cut its 2024 outlook following a "big" miss for its diabetes and weight-loss drugs. ... Mounjaro sales rocketed 121% to $3.11 billion ...

msn.com

2%
OFF

Eli Lilly Falls As Weight-loss Drug Sales Miss Estimates

3 weeks from now

Oct 30, 2024 · ** Shares of Eli Lilly NYSE:LLY slide 6.2% to $847.19, touching more than a two-month low, on track for biggest one-day percentage fall since March 2021** Co misses Wall …

tradingview.com

3%
OFF

Eli Lilly Dives On 'Big' Miss For Diabetes, Weight-Loss Drugs

3 weeks from now

Oct 30, 2024 · But on today's stock market, Eli Lilly stock plummeted 6.3% to 846.83. Shares undercut their 200-day line and the lower edge of a flat base with a buy point at 972.53, …

investors.com

38%
OFF

Eli Lilly Stock Soars As FDA Ends Weight Loss Drug Shortage

3 weeks from now

Dec 20, 2024 · How This Affects LLY Stock. LLY investors are celebrating today’s FDA news as it protects Eli Lilly’s sales of its GLP-1 drugs. With that comes an 8.38% increase in share price …

nasdaq.com

13%
OFF

Lilly And Novo Went Head-to-Head Over Weight-Loss Drugs In …

3 weeks from now

Despite ever-increasing sales, Eli Lilly stock is down 13% in the fourth quarter, while Novo’s American depositary receipts, or ADRs, are down 28%. Over the year, the difference is more …

msn.com

$100
OFF

The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion …

3 weeks from now

Dec 5, 2024 · An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in weight-loss drugs. The showdown centers on compounders, …

investors.com

8%
OFF

Hims & Hers Stock Slides After FDA Says Eli Lilly’s Weight-Loss …

3 weeks from now

Oct 3, 2024 · Shares of telehealth company Hims & Hers Health Inc. fell over 8% pre-market on Thursday following a key update from the federal government on weight-loss drug supply.Late …

stocktwits.com

FAQs about Eli Lilly Stock Slides Pre-Market On Weight-Loss Drug Sales Miss, … Coupon?

Why did Eli Lilly stock crash Wednesday?

Eli Lilly (LLY) stock crashed Wednesday after the pharma giant cut its 2024 outlook following a "big" miss for its popular diabetes and weight-loss drugs. The company's drug, tirzepatide, provides the backbone for diabetes treatment Mounjaro and weight-loss drug Zepbound. In the September quarter, Mounjaro sales rocketed 121% to $3.11 billion. ...

Why did Eli Lilly drop guidance on weight-loss drugs?

(Bloomberg) -- Eli Lilly & Co. lowered guidance Wednesday on lackluster sales of its weight-loss drug, which posted a shocking first miss that raised questions about the seemingly insatiable demand for the shots. Listen to the Here’s Why podcast on Apple, Spotify or anywhere you listen. ...

Why did Eli Lilly lose $70 billion?

(Reuters) -Eli Lilly's high profile weight-loss and diabetes drugs fell short of Wall Street sales estimates on Wednesday as supplies sat in warehouses, a 180-degree turn for the company after long struggling to meet outsized demand. Lilly shares were off 8%, wiping out nearly $70 billion from the Indianapolis-based drugmaker's market value. ...

Why did Eli Lilly's stock close 6% lower on Wednesday?

Eli Lilly on Wednesday fell short of profit and revenue expectations for the third quarter, weighed down by disappointing sales of its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro, and slashed its full-year adjusted profit guidance. The company's stock closed more than 6% lower on Wednesday. ...

Does Eli Lilly sell weight loss drugs?

Eli Lilly sells one of the most sought-after types of drugs today: weight loss drugs. The company’s Zepbound and Mounjaro have brought in blockbuster revenue, and more growth could be on the horizon. ...

Is Eli Lilly a good stock to buy?

Eli Lilly’s chunky valuation means it has little room for error. The shares have more than tripled since the start of 2022 to make the company the world’s most valuable drugmaker. Thanks to the frenzy for its weight-loss drugs, it had at its peak last month a market capitalisation of over $860bn. ...